» Articles » PMID: 20832487

Time-to-event Voxel-based Techniques to Assess Regional Atrophy Associated with MCI Risk of Progression to AD

Overview
Journal Neuroimage
Specialty Radiology
Date 2010 Sep 14
PMID 20832487
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: When using imaging to predict time to progression from mild cognitive impairment (MCI) to Alzheimer's disease (AD), time-to-event statistical methods account for varying lengths of follow-up times among subjects whereas two-sample t-tests in voxel-based morphometry (VBM) do not. Our objectives were to apply a time-to-event voxel-based analytic method to identify regions on MRI where atrophy is associated with significantly increased risk of future progression to AD in subjects with MCI and to compare it to traditional voxel-level patterns obtained by applying two-sample methods. We also compared the power required to detect an association using time-to-event methods versus two-sample approaches.

Methods: Subjects with MCI at baseline were followed prospectively. The event of interest was clinical diagnosis of AD. Cox proportional hazards models adjusted for age, sex, and education were used to estimate the relative hazard of progression from MCI to AD based on rank-transformed voxel-level gray matter density (GMD) estimates.

Results: The greatest risk of progression to AD was associated with atrophy of the medial temporal lobes. Patients ranked at the 25th percentile of GMD in these regions had more than a doubling of risk of progression to AD at a given time point compared to patients at the 75th percentile. Power calculations showed the time-to-event approach to be more efficient than the traditional two-sample approach.

Conclusions: We present a new voxel-based analytic method that incorporates time-to-event statistical methods. In the context of a progressive disease like AD, time-to-event VBM seems more appropriate and powerful than traditional two-sample methods.

Citing Articles

The use of individual-based FDG-PET volume of interest in predicting conversion from mild cognitive impairment to dementia.

Huang S, Hsiao W, Chang H, Ma M, Hsu S, Lee C BMC Med Imaging. 2024; 24(1):75.

PMID: 38549082 PMC: 10976703. DOI: 10.1186/s12880-024-01256-x.


Deep learning for risk-based stratification of cognitively impaired individuals.

Romano M, Zhou X, Balachandra A, Jadick M, Qiu S, Nijhawan D iScience. 2023; 26(9):107522.

PMID: 37646016 PMC: 10460987. DOI: 10.1016/j.isci.2023.107522.


Grey Matter Loss at Different Stages of Cognitive Decline: A Role for the Thalamus in Developing Alzheimer's Disease.

van de Mortel L, Thomas R, van Wingen G J Alzheimers Dis. 2021; 83(2):705-720.

PMID: 34366336 PMC: 8543264. DOI: 10.3233/JAD-210173.


Cognitive Reserve, Alzheimer's Neuropathology, and Risk of Dementia: A Systematic Review and Meta-Analysis.

Nelson M, Jester D, Petkus A, Andel R Neuropsychol Rev. 2021; 31(2):233-250.

PMID: 33415533 PMC: 7790730. DOI: 10.1007/s11065-021-09478-4.


Rates of lobar atrophy in asymptomatic mutation carriers.

Chen Q, Boeve B, Senjem M, Tosakulwong N, Lesnick T, Brushaber D Alzheimers Dement (N Y). 2019; 5:338-346.

PMID: 31388560 PMC: 6675939. DOI: 10.1016/j.trci.2019.05.010.


References
1.
Ashburner J, Friston K . Voxel-based morphometry--the methods. Neuroimage. 2000; 11(6 Pt 1):805-21. DOI: 10.1006/nimg.2000.0582. View

2.
Devanand D, Pradhaban G, Liu X, Khandji A, De Santi S, Segal S . Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease. Neurology. 2007; 68(11):828-36. DOI: 10.1212/01.wnl.0000256697.20968.d7. View

3.
Chetelat G, Landeau B, Eustache F, Mezenge F, Viader F, De La Sayette V . Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: a longitudinal MRI study. Neuroimage. 2005; 27(4):934-46. DOI: 10.1016/j.neuroimage.2005.05.015. View

4.
Braak H, Braak E . Evolution of the neuropathology of Alzheimer's disease. Acta Neurol Scand Suppl. 1996; 165:3-12. DOI: 10.1111/j.1600-0404.1996.tb05866.x. View

5.
McDonald C, McEvoy L, Gharapetian L, Fennema-Notestine C, Hagler Jr D, Holland D . Regional rates of neocortical atrophy from normal aging to early Alzheimer disease. Neurology. 2009; 73(6):457-65. PMC: 2727145. DOI: 10.1212/WNL.0b013e3181b16431. View